Get the Stockscreener App
20.98
3.76%
-0.82
Pre-market:
21.12
0.14
+0.67%
Enovis Corp stock is traded at $20.98, with a volume of 845.45K.
It is down -3.76% in the last 24 hours and down -13.63% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$21.80
Open:
$22.37
24h Volume:
845.45K
Relative Volume:
0.86
Market Cap:
$1.21B
Revenue:
$2.28B
Net Income/Loss:
$-1.13B
P/E Ratio:
-1.0564
EPS:
-19.86
Net Cash Flow:
$35.92M
1W Performance:
-11.40%
1M Performance:
-13.63%
6M Performance:
-20.95%
1Y Performance:
-34.23%
1-Day Range:
$20.80
$22.71
1-Week Range:
$20.55
$24.58
52-Week Range:
$20.55
$36.82
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
20.98 | 1.21B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Enovis CAO Oliver Engert acquires $25,948 in company stock - Investing.com UK
Enovis CAO Oliver Engert acquires $25,948 in company stock By Investing.com - Investing.com South Africa
Enovis (ENOV) CAO Oliver Engert adds 1,200 shares in open-market buys - Stock Titan
Is Enovis (ENOV) Using Spinamic to Quietly Redefine Its Orthopedic Innovation Playbook? - simplywall.st
A Look at Enovis Corp (ENOV) After 3.2% Gain -- GF Value $50.02 vs Price $21.80 - GuruFocus
Enovis stock hits 52-week low at 20.79 USD By Investing.com - Investing.com Nigeria
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Enovis chief administrative officer Engert buys $23,000 in stock By Investing.com - Investing.com South Africa
Enovis chief administrative officer Engert buys $23,000 in stock - Investing.com
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open market - Stock Titan
Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12%News and Statistics - IndexBox
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness - Yahoo Finance
Enovis stock hits 52-week low at 20.79 USD - Investing.com
CD&R Appoints Former Enovis CEO Matthew Trerotola as Operating Advisor - citybiz
CD&R Engages Former Enovis CEO as Operating Advisor — CD&R | Building Businesses Building Value - CD&R
Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock? - Insider Monkey
How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets - Yahoo Finance
Is Enovis (ENOV) Using Spinamic To Quietly Redefine Its Orthopedics Innovation Edge? - Yahoo Finance
Enovis Launches Spinamic Hybrid Scoliosis Brace for Pediatric Patients - geneonline.com
Enovis launches hybrid scoliosis brace in U.S. market By Investing.com - Investing.com South Africa
Enovis launches hybrid scoliosis brace in U.S. market - Investing.com
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining - GlobeNewswire
Why Enovis (ENOV) Is Up 9.6% After Beating Q1 Targets And Enhancing Incentive Plan Alignment - simplywall.st
A Look At Enovis (ENOV) Valuation As Shares Rebound And Long Term Returns Lag - simplywall.st
3 Reasons ENOV is Risky and 1 Stock to Buy Instead - Yahoo Finance UK
Top Enovis (ENOV) Competitors 2026 - MarketBeat
Enovis (ENOV): Revenue Beat, Margins Expand and Full-Year Outlook Maintained - Insider Monkey
Enovis Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Enovis Corp Stock Baskets - GuruFocus
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Enovis chief administrative officer buys $22,220 in company stock By Investing.com - Investing.com South Africa
Enovis chief administrative officer buys $22,220 in company stock - Investing.com
Enovis (ENOV) Chief Administrative Officer buys 1,000 shares in open market - Stock Titan
Enovis Corp stock hits 52-week low at $20.96 By Investing.com - Investing.com Canada
Enovis Corp stock hits 52-week low at $20.96 - Investing.com
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - AOL.com
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout
Enovis (ENOV) Earnings Date and Reports 2026 - MarketBeat
Enovis Corporation (ENOV) Holds Steady Near Support as Consolidation ContinuesETF Creation Redemption - thelegaladvocate.com
Enovis Corporation (ENOV) Sinks 7.15%: Assessing Support Levels and Potential ReversalMA Crossover - thelegaladvocate.com
Earnings Preview: Enovis Corp to Report Financial Results Pre-market on May 07 - Moomoo
A Look At Enovis (ENOV) Valuation After ESOP Shelf Registration For Up To 3,650,000 Shares - simplywall.st
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):